40.28
Schlusskurs vom Vortag:
$39.12
Offen:
$40.06
24-Stunden-Volumen:
211.42K
Relative Volume:
0.24
Marktkapitalisierung:
$2.36B
Einnahmen:
$277.49M
Nettoeinkommen (Verlust:
$-192.14M
KGV:
-11.99
EPS:
-3.36
Netto-Cashflow:
$-95.52M
1W Leistung:
+2.36%
1M Leistung:
-15.19%
6M Leistung:
-14.04%
1J Leistung:
+16.78%
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TWST
Twist Bioscience Corp
|
40.38 | 2.36B | 277.49M | -192.14M | -95.52M | -3.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
517.66 | 195.34B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
208.91 | 149.60B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
119.56 | 33.84B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IDXX
Idexx Laboratories Inc
|
413.33 | 33.52B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
184.24 | 32.24B | 15.41B | 1.37B | 2.11B | 7.50 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
2024-06-04 | Eingeleitet | Guggenheim | Buy |
2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
2023-09-27 | Eingeleitet | Berenberg | Buy |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
2022-03-02 | Fortgesetzt | Cowen | Outperform |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-06-29 | Eingeleitet | William Blair | Outperform |
2021-06-04 | Eingeleitet | Goldman | Neutral |
2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? - Yahoo Finance
Twist Bioscience at Barclays Conference: Strategic Growth Amid Challenges - Investing.com
Victory Capital Management Inc. Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience at Leerink Conference: Strategic Growth Amid Challenges - Investing.com
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost - Yahoo Finance
Twist Bioscience’s Dennis Cho sells $11,332 in stock - Investing.com India
Twist Bioscience’s Dennis Cho sells $11,332 in stock By Investing.com - Investing.com Australia
Twist Bioscience SVP Paula Green sells $37,558 in stock By Investing.com - Investing.com South Africa
Twist Bioscience CEO Emily Leproust sells shares worth $98,273 - Investing.com
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Bank of New York Mellon Corp Decreases Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 4.47% on Feb 7 - GuruFocus.com
Twist Bioscience director Robert Chess sells shares totaling $156,216 - MSN
Why Investors Shouldn't Be Surprised By Twist Bioscience Corporation's (NASDAQ:TWST) 26% Share Price Plunge - Simply Wall St
Twist Bioscience Co. (NASDAQ:TWST) Receives $54.40 Average Price Target from Brokerages - Defense World
Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday - Benzinga
Handelsbanken Fonder AB Purchases New Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Rhumbline Advisers Raises Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
ARK Investment Management LLC Purchases 237,772 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp. to Host Earnings Call - ACCESS Newswire
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $54.40 - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Principal Financial Group Inc. - Defense World
New York State Common Retirement Fund Has $20.54 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire
Van ECK Associates Corp Acquires 267 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Is Now The Time To Buy Twist Bioscience Corp (NASDAQ: TWST) Stock? - Stocks Register
Baillie Gifford & Co. Cuts Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
Cathie Wood’s ARK ETF adds Twist Bioscience, Beam Therapeutics stock By Investing.com - Investing.com Australia
Cathie Wood's ARK ETF adds Twist Bioscience, Beam Therapeutics stock - Investing.com
Cathie Wood’s ARK ETF adds Twist Bioscience, Beam Therapeutics stock - Investing.com India
Cathie Wood's ARK ETF adds Twist Bioscience, Beam Therapeutics stock By Investing.com - Investing.com UK
Bioscience industry in Oregon outpaces overall job growth - The Business Journals
Twist Bioscience Co. (NASDAQ:TWST) Director Robert Chess Sells 2,940 Shares - MarketBeat
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday - Benzinga
IBD Rating Upgrades: Twist Bioscience Shows Improved Relative Price Strength - MSN
Twist Bioscience (NASDAQ:TWST) Stock Price Down 5.8%Here's What Happened - MarketBeat
Cathie Wood's ARK sells Palantir and Roku, buys more Twist Bioscience - MSN
Twist Bioscience Reports Record Quarterly Revenue - TipRanks
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Twist Bioscience approves stock increase, officer exculpation - MSN
Twist Bioscience approves stock increase, officer exculpation By Investing.com - Investing.com Australia
Director’s Strategic Sale of Twist Bioscience Shares - TipRanks
Twist Bioscience director Robert Chess sells shares totaling $156,216 By Investing.com - Investing.com Nigeria
Twist Bioscience Stockholders Approve Key Amendments - TipRanks
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Cho Dennis | See Remarks |
Mar 06 '25 |
Sale |
40.91 |
277 |
11,333 |
111,984 |
Leproust Emily M. | Chief Executive Officer |
Mar 06 '25 |
Sale |
40.91 |
2,402 |
98,273 |
662,692 |
WERNER ROBERT F. | Chief Accounting Officer |
Mar 06 '25 |
Sale |
40.91 |
241 |
9,860 |
51,434 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):